Company intelligence / Profile preview

ChemeGen

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

ChemeGen is a private life science reagents and research chemicals supplier focused on active small molecules, including inhibitors, agonists, and related life science reagents for research use. The company markets a catalog of more than 10,000 compounds and positions its offerings to support signaling pathway research, especially in cancer and inflammation. In addition to catalog products, ChemeGen advertises custom synthesis, scale-up, lead-compound chemical modification, and selected cell biology services. Based on available public information, it appears to be a commercial research-tools company rather than a therapeutic drug developer with a disclosed clinical pipeline.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on ChemeGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemeGen.

Explore the full profile